6505--MISSION CRITICAL - NEW VISN ASSISTED PHARMACY LENALIDOMIDE (VA-26-00030335)
ID: 36C25526Q0127Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF255-NETWORK CONTRACT OFFICE 15 (36C255)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/f5cbc88d6a9340d1ab78f31987168385/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide procurement services for generic Lenalidomide as part of a mission-critical program within the Veterans Integrated Service Network (VISN) 15. This procurement will support the treatment of Veterans diagnosed with specific medical conditions, requiring a firm-fixed price, Indefinite Delivery Indefinite Quantity (IDIQ) contract for the supply of this essential medication. Lenalidomide is a critical antineoplastic agent used in the treatment of various cancers, and its procurement is vital for maintaining the health and well-being of Veterans under the care of multiple VA Medical Centers across Missouri and Kansas. Interested parties must respond to the Sources Sought Notice by December 23, 2025, at 3:00 PM CST, and can direct inquiries to Contracting Officer Michael Murphy at michael.murphy7@va.gov.

    Point(s) of Contact
    Murphy, MichaelContracting Officer
    (913) 946-1963
    michael.murphy7@va.gov
    Files
    Title
    Posted
    36C25526Q0127.docx
    The Department of Veterans Affairs (VA) Network Contracting Office (NCO) 15 has issued a Sources Sought Notice (Solicitation Number 36C25526Q0127) for a mission-critical new VISN Assisted Pharmacy Lenalidomide program. The notice, with a response deadline of December 24, 2025, at 3:00 PM Central Time, seeks information for a project related to pharmaceutical products (PSC 6505) and drug manufacturing (NAICS 325412). The place of performance includes various VA Medical Centers within VISN 15, specifically Columbia, Poplar Bluff, Marion, St. Louis, Leavenworth, Wichita, and Kansas City, MO. Michael Murphy is the contracting officer and point of contact for this notice.
    Lifecycle
    Title
    Type
    6505--MISSION CRITICAL - NEW VISN ASSISTED PHARMACY LENALIDOMIDE (VA-26-00030335)
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    Lenalidomide/Revlimid - Brand Name or Equal
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Lenalidomide/Revlimid medication, either brand name or equal, for the Edward Hines Jr. VA Hospital Pharmacy Service in Hines, Illinois. This procurement includes the delivery of various dosages of Lenalidomide capsules for a contract period from January 5, 2026, to January 4, 2027, and requires that the successful offeror be a pharmacy certified with the Lenalidomide Risk Evaluation and Mitigation Strategy (REMS) program. The medication is critical for treating certain conditions, and the procurement process will be based on the lowest price technically acceptable offers, with payment processing handled electronically through the Tungsten Network. Interested parties must submit their quotes via email to the primary contact, Arneil Genus, at arneil.genus@va.gov by the deadline of December 26, 2025, at 3 PM CST.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for operational and mailing supplies to support seven Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States. The procurement includes a wide range of items such as resealable bags, corrugated boxes, various types of mailers, child-resistant medical pouches, and packaging materials, all of which must adhere to specific material and postal regulations. This contract is crucial for ensuring the efficient operation of CMOP facilities, which play a vital role in delivering medications to veterans. Interested parties should contact Kelly L Mann at kelly.mann@va.gov or Larry Zaritz at larry.zaritz@va.gov for further details, and must review the attached documents, including the pricing schedule and past performance requirements, as submissions are due by the specified deadlines.
    6505--LANSOPRAZOLE
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Lansoprazole, a pharmaceutical product, for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This procurement is justified as a sole source requirement, indicating that Lansoprazole is essential for the pharmacy's operations and patient care. The drug falls under the category of drugs and biologicals, highlighting its critical role in treating various medical conditions. Interested vendors can reach out to Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov or by phone at 913-946-0150 for further details regarding this opportunity.
    DA01--State Prescription Drug Monitoring Program (PDMP) Integration Solution and Support Services - New Task Order (VA-26-00013141)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide integration solutions and sustainment support services for its State Prescription Drug Monitoring Program (PDMP) under task order VA-26-00013141. The procurement aims to maintain and enhance the existing PDMP solution, which connects VA healthcare providers to a national network of state-based PDMPs, facilitating the querying of controlled substance prescriptions. This initiative is crucial for improving patient safety and ensuring compliance with the MISSION Act Section 134. Interested vendors, particularly Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs) certified by the SBA's VetCert program, must submit their responses by January 5, 2026, at 10 AM EST, detailing their technical capabilities and experience, with a focus on the requirements outlined in the attached Request for Information documents. For further inquiries, contact Contract Specialist Edward Olivo-Cruz at Edward.Olivo-Cruz@va.gov or 848-377-5099.